Loading...
Shandong Weigao Group Medical Polymer Company Limited
SHWGF•PNK
Healthcare
Medical - Instruments & Supplies
$0.76
$0.00(0.00%)
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Financial Performance & Income Statement Overview
Review Shandong Weigao Group Medical Polymer Company Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.08%
↓ 1.08%
Operating Income Growth
9.44%
↑ 9.44%
Net Income Growth
3.24%
↑ 3.24%
Operating Cash Flow Growth
-0.31%
↓ 0.31%
Operating Margin
18.23%
↑ 18.23%
Gross Margin
50.28%
↑ 50.28%
Net Profit Margin
15.79%
↑ 15.79%
ROE
8.95%
↑ 8.95%
ROIC
8.32%
↑ 8.32%
Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Income Statement & Financial Overview
Review Shandong Weigao Group Medical Polymer Company Limited's (SHWGF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.23B | $3.23B | $3.32B | $3.32B |
| Cost of Revenue | $1.65B | $1.65B | $1.63B | $1.63B |
| Gross Profit | $1.58B | $1.58B | $1.69B | $1.69B |
| Gross Profit Ratio | $0.49 | $0.49 | $0.51 | $0.51 |
| R&D Expenses | $161.81M | $161.81M | $150.81M | $150.81M |
| SG&A Expenses | $912.89M | $912.89M | $905.91M | $905.91M |
| Operating Expenses | $1.07B | $1.07B | $1.06B | $1.06B |
| Total Costs & Expenses | $2.72B | $2.72B | $2.69B | $2.69B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $217.35M | $217.41M | $217.41M | $217.41M |
| EBITDA | $722.26M | $722.32M | $848.92M | $848.92M |
| EBITDA Ratio | $0.22 | $0.22 | $0.26 | $0.26 |
| Operating Income | $504.91M | $504.91M | $631.51M | $631.51M |
| Operating Income Ratio | $0.16 | $0.16 | $0.19 | $0.19 |
| Other Income/Expenses (Net) | $88.77M | $88.77M | $51.68M | $51.68M |
| Income Before Tax | $593.68M | $593.68M | $683.19M | $683.19M |
| Income Before Tax Ratio | $0.18 | $0.18 | $0.21 | $0.21 |
| Income Tax Expense | $89.11M | $89.11M | $106.40M | $106.40M |
| Net Income | $479.56M | $479.56M | $553.77M | $553.77M |
| Net Income Ratio | $0.15 | $0.15 | $0.17 | $0.17 |
| EPS | $0.10 | $0.10 | $0.12 | $0.12 |
| Diluted EPS | $0.10 | $0.10 | $0.12 | $0.12 |
| Weighted Avg Shares Outstanding | $4.67B | $4.67B | $4.61B | $4.61B |
| Weighted Avg Shares Outstanding (Diluted) | $4.57B | $4.57B | $4.61B | $4.61B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan